Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?

To: KLH who wrote (216)	7/21/1999 1:09:00 PM
From: BWAC	Read Replies (1) \| Respond to of 405

Karl, I've put in a call to GZTR/GENZ and asked them to call me. I have one basic question to ask them. Maybe 2. I'll run it by you to make sure I'm not totally nuts? Facts as we know them: GZTR is moving/hoping/planning towards being a profitable company in the next 2 years. Directors of GZTR and GENZ have been buying. The price is arguablly severely depressed as valued upon the technology that GZTR possesses. Q. Given the above (especially the directors actions), would it be proper/doable/appropriate for GENZ to go out into the open market and purchase shares of GZTR? (GENZ has 600 Million of cash equivs., so it is doable.) Q. Has any thought been given to the above question. If not, why? My thinking is simply that the market is ignoring whatever message it is that GZTR has to send. Nobody is paying any attention at all. The GENZ/GZTR directors are putting up their own money now. Would it not be prudent for them to reclaim some of the investment in GZTR for the GENZ shareholders also?